R. Mendes

4.7k total citations
26 papers, 542 citations indexed

About

R. Mendes is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, R. Mendes has authored 26 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 8 papers in Radiation. Recurrent topics in R. Mendes's work include Advanced Radiotherapy Techniques (8 papers), Head and Neck Cancer Studies (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). R. Mendes is often cited by papers focused on Advanced Radiotherapy Techniques (8 papers), Head and Neck Cancer Studies (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). R. Mendes collaborates with scholars based in United Kingdom and United States. R. Mendes's co-authors include B.E. Souberbielle, Ian E. Smith, Mary O’Brien, James L. Bedford, Michael Westby, Christopher M. Nutting, Ricky A. Sharma, Joanna Galea‐Lauri, Syed Moinuddin and Michael Brada and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

R. Mendes

26 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Mendes United Kingdom 13 205 197 174 119 114 26 542
Yongmei Liu China 14 85 0.4× 123 0.6× 336 1.9× 108 0.9× 174 1.5× 31 684
Ali El‐Gayed Canada 11 171 0.8× 219 1.1× 149 0.9× 81 0.7× 87 0.8× 18 378
Alessandra Franzetti-Pellanda Switzerland 8 88 0.4× 155 0.8× 147 0.8× 39 0.3× 75 0.7× 19 360
Maximilian Knoll Germany 11 99 0.5× 45 0.2× 123 0.7× 54 0.5× 107 0.9× 39 516
Do Hoon Oh South Korea 12 112 0.5× 185 0.9× 134 0.8× 115 1.0× 20 0.2× 34 456
Hans Blaauwgeers Netherlands 11 106 0.5× 41 0.2× 293 1.7× 171 1.4× 165 1.4× 21 587
T. Ström United States 11 62 0.3× 65 0.3× 138 0.8× 28 0.2× 281 2.5× 32 448
Subhashini John India 12 59 0.3× 34 0.2× 73 0.4× 75 0.6× 94 0.8× 31 449
Slaven Jurković Croatia 10 146 0.7× 173 0.9× 136 0.8× 33 0.3× 24 0.2× 45 311
S Becker United States 11 165 0.8× 312 1.6× 235 1.4× 22 0.2× 56 0.5× 51 628

Countries citing papers authored by R. Mendes

Since Specialization
Citations

This map shows the geographic impact of R. Mendes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Mendes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Mendes more than expected).

Fields of papers citing papers by R. Mendes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Mendes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Mendes. The network helps show where R. Mendes may publish in the future.

Co-authorship network of co-authors of R. Mendes

This figure shows the co-authorship network connecting the top 25 collaborators of R. Mendes. A scholar is included among the top collaborators of R. Mendes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Mendes. R. Mendes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sidhu, Harbir, Νικόλαος Δικαίος, Saurabh Singh, et al.. (2021). Utility of diffusion MRI characteristics of cervical lymph nodes as disease classifier between patients with head and neck squamous cell carcinoma and healthy volunteers. NMR in Biomedicine. 34(11). e4587–e4587. 1 indexed citations
3.
Amos, Richard A., Andrew Poynter, S. Gulliford, et al.. (2020). Retrospective Planning Study of Patients with Superior Sulcus Tumours Comparing Pencil Beam Scanning Protons to Volumetric-Modulated Arc Therapy. Clinical Oncology. 33(3). e118–e131. 3 indexed citations
4.
Kosmin, Michael, Joseph R. Ledsam, Bernardino Romera‐Paredes, et al.. (2019). Rapid advances in auto-segmentation of organs at risk and target volumes in head and neck cancer. Radiotherapy and Oncology. 135. 130–140. 99 indexed citations
5.
Ricketts, Kate, et al.. (2018). A methodology to extract outcomes from routine healthcare data for patients with locally advanced non-small cell lung cancer. BMC Health Services Research. 18(1). 278–278. 2 indexed citations
6.
Förster, Martin, R. Mendes, Kevin J. Harrington, et al.. (2016). ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck.. Journal of Clinical Oncology. 34(15_suppl). TPS6108–TPS6108. 4 indexed citations
7.
Eminowicz, Gemma, R. Mendes, Jamie R. McClelland, et al.. (2015). Validation of clinical acceptability of an atlas‐based segmentation algorithm for the delineation of organs at risk in head and neck cancer. Medical Physics. 42(9). 5027–5034. 46 indexed citations
8.
Förster, Martin, R. Mendes, & Stefano Fedele. (2012). Synthetic Lethality and PARP-Inhibitors in Oral and Head & Neck Cancer. Current Pharmaceutical Design. 18(34). 5431–5441. 8 indexed citations
9.
Panakis, N., H. McNair, Judith Christian, et al.. (2008). Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters. Radiotherapy and Oncology. 87(1). 65–73. 68 indexed citations
10.
11.
Bedford, James L., Peter J. Childs, Vibeke N. Hansen, et al.. (2005). Treatment of extensive scalp lesions with segmental intensity-modulated photon therapy. International Journal of Radiation Oncology*Biology*Physics. 62(5). 1549–1558. 39 indexed citations
12.
Urruticoechea, Ander, Caroline Archer, L. Assersohn, et al.. (2005). Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer. British Journal of Cancer. 92(3). 475–479. 14 indexed citations
13.
Mendes, R., Christopher M. Nutting, & Kevin J. Harrington. (2004). Residual or recurrent head and neck cancer presenting with nerve root compression affecting the upper limbs. British Journal of Radiology. 77(920). 688–690. 10 indexed citations
14.
Mendes, R., Mary O’Brien, Abhishek Mitra, et al.. (2002). Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma. British Journal of Cancer. 86(3). 336–341. 18 indexed citations
15.
Assersohn, L., B.E. Souberbielle, Mary O’Brien, et al.. (2002). A Randomized Pilot Study of SRL172 ( ) in Patients with Small Cell Lung Cancer (SCLC) Treated with Chemotherapy. Clinical Oncology. 14(1). 23–27. 24 indexed citations
16.
Hirst, W J R, et al.. (2001). Whole blood assay for assessment of the mixed lymphocyte reaction. Journal of Immunological Methods. 247(1-2). 1–8. 12 indexed citations
17.
Mendes, R., Michael Westby, Joanna Galea‐Lauri, et al.. (2000). Flow cytometric visualisation of cytokine production by CD3-CD56+ NK cells and CD3+CD56+ NK-T cells in whole blood. Cytometry. 39(1). 72–78. 51 indexed citations
18.
O’Brien, Mary, Andrea Saini, Ian E. Smith, et al.. (2000). A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma. British Journal of Cancer. 83(7). 853–857. 66 indexed citations
19.
Mendes, R., et al.. (1999). A whole blood facscan assay to look at cytokine production by NK cells in cancer patients.. British Journal of Cancer. 80. 85–85. 15 indexed citations
20.
Souberbielle, B.E., et al.. (1998). Comparison of four strategies for tumour vaccination in the B16-F10 melanoma model. Gene Therapy. 5(11). 1447–1454. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongmei Liu Breakdown of academic impact, for papers by Ali El‐Gayed Breakdown of academic impact, for papers by Alessandra Franzetti-Pellanda Breakdown of academic impact, for papers by Maximilian Knoll Breakdown of academic impact, for papers by Do Hoon Oh Breakdown of academic impact, for papers by Hans Blaauwgeers Breakdown of academic impact, for papers by T. Ström Breakdown of academic impact, for papers by Subhashini John Breakdown of academic impact, for papers by Slaven Jurković Breakdown of academic impact, for papers by S Becker
Rankless by CCL
2026